PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -25.80 | -1.74% | 1,457.80 | 1,457.60 | 1,458.00 | 1,484.20 | 1,455.40 | 1,478.60 | 12,816,995 | 16:29:59 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 34,114.0 | 5,442.0 | 87.6 | 16.6 | 59,294 |
Gsk (GSK) News Headlines
Gsk News
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/12/2022 | 15:08 | DJN | Trending: GSK, Sanofi in Focus After U.S. Judge Dismisses Zantac Lawsuit |
| 07/12/2022 | 09:28 | DJN | Sanofi, GSK Shares Jump After Zantac Lawsuit Dismissal |
| 07/12/2022 | 07:00 | UKREG | GSK PLC Statement: Zantac (ranitidine) litigation |
| 06/12/2022 | 21:59 | ALNC |  TOP NEWS: GSK welcomes Zantac legal boost in Florida |
| 05/12/2022 | 16:00 | UKREG | GSK PLC Transfer of Treasury Shares |
| 02/12/2022 | 22:37 | DJN | ADRs End Mostly Higher, H World and RedHill BioPharma Trade Actively |
| 02/12/2022 | 15:30 | UKREG | GSK PLC Director/PDMR Shareholding |
| 02/12/2022 | 15:11 | DJN | AnaptysBio: Trial of Jemperli Drug Meets Primary Endpoint |
| 02/12/2022 | 08:47 | ALNC | TOP NEWS: GSK gets EMA validation for bone marrow cancer treatment |
| 02/12/2022 | 07:47 | DJN | GSK Phase 3 Trial for Jemperli Endometrial Cancer Treatment Met Primary.. |
1 Year Gsk Chart |
Intraday Gsk Chart |